Chagas' disease, caused by the protozoan parasite Trypanosoma cruzi, repres
ents a major public health problem in most of the American continent. As tr
ansmission of the parasite is being interrupted in most of South America, t
he disease remains endemic in various areas of Mexico. We review here some
of the information gathered in recent years. Seroprevalence of T. cruzi inf
ection in humans remains relatively high in some areas, and there has been
a general increase in the number of chronic cases reported to health author
ities in recent years. In fact, chronic chagasic cardiomyopathy appears to
be affecting a large number of patients with heart disease, but many cases
may be misreported because of the unspecific nature of the clinical symptom
s. Epidemiological monitoring of vector and reservoir populations, as well
as of human cases is helping focus on endemic areas, but a better coordinat
ion and development of these efforts is still needed. Recent studies of par
asite biology are in agreement with previous work showing the great diversi
ty of parasite characteristics, and support the need for a regional approac
h to this zoonosis. Strong and continuing support from health and academic
authorities is thus still needed to further improve our understanding of Ch
agas' disease in Mexico and implement efficient control programs.